Abstract

1548Background: The management of women with BC includes GCRA for those at risk of carrying deleterious BRCA mutations. GCRA can aid decisions regarding RRS, including contralateral risk reducing m...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract IA23: Steps to address the profound disparity in access to genetic cancer risk assessment in Mexico: Documenting hereditary breast and ovarian cancer and the beginning of a prevention program
Cynthia Villarreal-Garza
Cancer Epidemiology, Biomarkers & Prevention | VOL. 24
Cynthia Villarreal-GarzaCynthia Villarreal-Garza
30 Sep 2015
Abstract P6-09-05: Factors associated with the uptake of risk-reducing surgeries among Hispanic women at high risk of breast and ovarian cancer
...
Cancer Research | VOL. 78
, et. al. ...
14 Feb 2018
Abstract PS8-25: Genetic cancer risk assessment and its impact on the uptake of cancer risk reduction strategies: The experience of a Mexican center
Dione Aguilar ... Nancy L Sada-Villarreal
Cancer Research | VOL. 81
Dione Aguilar, et. al.Dione Aguilar ... Nancy L Sada-Villarreal
15 Feb 2021
Abstract A50: Differences in perceived personal control among Latina women undergoing genetic cancer risk assessment for hereditary breast and ovarian cancer
Tanya A Chavez ... Bita Nehoray
Cancer Epidemiology, Biomarkers & Prevention | VOL. 25
Tanya A Chavez, et. al.Tanya A Chavez ... Bita Nehoray
01 Mar 2016
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Molecular Expression Assays Improve the Prediction of Local and Invasive Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
Ezra Hahn ... Danielle Rodin
Journal of Clinical Oncology | VOL. -
Ezra Hahn, et. al.Ezra Hahn ... Danielle Rodin
28 Jun 2024
Effect of an Invitation or the Effect of Participation: What Should Randomized Controlled Trials of Cancer Screening Examine?
Peter D Sasieni
Journal of Clinical Oncology | VOL. -
Peter D SasieniPeter D Sasieni
28 Jun 2024
Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic Syndromes
Corey Cutler
Journal of Clinical Oncology | VOL. -
Corey CutlerCorey Cutler
28 Jun 2024
Reply to S. Sorscher
Julia Butt ... Meira Epplein
Journal of Clinical Oncology | VOL. -
Julia Butt, et. al.Julia Butt ... Meira Epplein
27 Jun 2024
View more papers